Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company on a path to emerging as a pioneering force in the development of digital assets and SEC-registered security tokens, recently announced a strategic investment into Avrio Worldwide PBC, purchasing a 24% stake in the company. Avrio is a registered market infrastructure provider with a full technology stack and recently acquired the HUMBL Financial brand, products, and services (https://ibn.fm/xbFRN).
Avrio is the parent company of a portfolio of companies that deliver licensed digital financial market infrastructure and solutions across public, private, and digital markets. Avrio’s partnership with HUMBL Financial provides HUMBL with the global market access needed to efficiently execute its strategies and scale rapidly in a competitive and complex market environment across stocks, options, crypto, commodities, and digital assets – including traditional financial products and services customers would expect inside digital wallets and web platforms.
“HUMBL Financial has developed new and innovative products, such as the BLOCK Indexes and BLOCK ETXs, that give retail investors new ways to access digital assets and also deliver a range of new consumer financial products and services into digital wallets and web3 platforms,” said Lawrence Wintermeyer, CEO of Avrio. “HUMBL becomes a significant stakeholder in Avrio with this agreement, and we look forward to representing the HUMBL Financial brand and shareholders across the Avrio platform and network.”
In addition to the HUMBL Financial acquisition, Avrio also announced a 1:10 share exchange agreement, resulting in a bi-directional common stock acquisition between the company and SocialTrader.AI. SocialTrader will offer AI-driven investment strategies, risk management, and education for the new generation of traders and investors using the company’s global digital financial market infrastructure. This deal marks another milestone for Avrio’s ecosystem of companies that will develop and scale new, innovative digital financial products and services across multiple markets (https://ibn.fm/S71vw).
SocialTrader is an AI-powered, consumer fintech platform providing affordable access to professional investing tools. Its advanced investment platform combines AI, quantitative trading, investment strategies, and risk management with robust security. The company will deploy Avrio’s digital financial market infrastructure to access public, private, and digital markets across multiple asset classes.
Alfonso Arana, Co-founder and CEO of SocialTrader, said Avrio’s state-of-the-art digital financial market infrastructure will power the SocialTrader platform with cost-efficient, secure, and reliable access to global markets. “The experience of its management team of traders, quants, and investment managers will be invaluable in supporting SocialTrader through the development of its next-generation product roadmap, allowing its users to invest in stocks, options, commodities, ETXs, and quantitative investment products that will expand the range and depth of access to assets and markets for global retail investors,” Arana added.
Avrio’s public market technology includes an API farm for exchange management (“EM”), order management (“OM”), portfolio management (“PM”), and client management (“CM”), as well as routes to global public markets. Avrio’s NFT technology provides exchange access and capabilities to trade digital assets and collectibles.
For more information, visit the company’s website at www.DiamondLakeMinerals.com or LinkedIn page at www.LinkedIn.com/company/Diamond-Lake-Minerals/.
In addition, for information on the company’s security token SEC-regulated exchange partner INX and the development of the INX Way, visit https://www.inx.co/inx-ebook/. This free security token bible, written with the SEC on the rollout of security tokens and the future of digital assets, will greatly deepen your understanding of security tokens.
NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI
About TinyGems
TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.TinyGems.com
Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer
TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com
TinyGems is powered by IBN
Scientists have overcome production barriers that have plagued doxorubicin manufacturing since the 1970s by engineering…
LIXTE’s lead compound, LB-100, is the world’s first and only clinical-stage inhibitor of protein phosphatase…
Cancer patients with healthier thymus glands show dramatically better responses to immunotherapy, cutting progression risks by roughly…
Researchers are increasingly focused on combination therapies and novel mechanisms of action that can enhance…
LIXT is developing LB-100, a first-in-class therapy designed to enhance the effectiveness of established cancer…
Artificial intelligence has moved from a background tool into a visible presence in American political…